SEARCH

SEARCH BY CITATION

References

  • Bishop, J.F., Matthews, J.P., Mcgrath, K., Yuen, K., Wolf, M.M. & Szer, J. (1991) Factors influencing 20-hour increments after platelet transfusion. Transfusion, 31, 392396.
  • Cawley, C., McDonald, C., Ancliff, S., Roy, A., Maclennan, S., Brant, L., Pichon, B. & Brailsford, S. (2011) Early recognition and reporting of suspected bacterial contamination may prevent transfusion transmission of infection by associated units. Transfusion Medicine, 21, 7072.
  • Cazenave, J.P., Waller, C., Kientz, D., Mendel, I., Lin, L., Jacquet, M., Propst, M., Liu, W., Corash, L., Sundin, D., Defoin, L., Messe, N. & Osselaer, J.C. (2010) An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment. Transfusion, 50, 12101219.
  • Cognasse, F., Osselaer, J.C., Payrat, J.M., Chavarin, P., Corash, L. & Garraud, O. (2008) Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion, 48, 809813.
  • Davis, K.B., Slichter, S.J. & Corash, L. (1999) Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion, 39, 586592.
  • Dumont, L.J., Kleinman, S., Murphy, J.R., Lippincott, R., Schuyler, R., Houghton, J. & Metzel, P. (2010) Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion, 50, 589599.
  • Eder, A.F., Kennedy, J.M., Dy, B.A., Notari, E.P., Skeate, R., Bachowski, G., Mair, D.C., Webb, J.S., Wagner, S.J., Dodd, R.Y. & Benjamin, R.J. (2009) Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion, 49, 15541563.
  • Esber, E. (1986) Reduction of the Maximum Platelet Storage Period to 5 Days in an Approved Container. FDA memorandum . U.S. Food and Drug Administration, Rockville, MD, USA.
  • Grass, J.A., Hei, D.J., Metchette, K., Cimino, G.D., Wiesehahn, G.P., Corash, L. & Lin, L. (1998) Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood, 91, 21802188.
  • Janetzko, K., Cazenave, J.P., Kluter, H., Kientz, D., Michel, M., Beris, P., Lioure, B., Hastka, J., Marblie, S., Mayaudon, V., Lin, L., Lin, J.S., Conlan, M.G. & Flament, J. (2005) Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion, 45, 14431452.
  • Kerkhoffs, J.L., Eikenboom, J.C., Schipperus, M.S., Wordragen-Vlaswinkel, R.J., Brand, R., Harvey, M.S., de Vries, R.R., Barge, R., van Rhenen, D.J. & Brand, A. (2006) A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood, 108, 32103215.
  • Kerkhoffs, J.L., van Putten, W.L., Novotny, V.M., te Boekhorst, P.A., Schipperus, M.R., Zwaginga, J.J., van Pampus, L.C., de Greef, G.E., Luten, M., Huijgens, P.C., Brand, A. & van Rhenen, D.J. (2010) Clinical effectiveness of leukoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. British Journal of Haematology, 150, 209217.
  • Lin, L., Cook, D.N., Wiesehahn, G.P., Alfonso, R., Behrman, B., Cimino, G.D., Corten, L., Damonte, P.B., Dikeman, R., Dupuis, K., Fang, Y.M., Hanson, C.V., Hearst, J.E., Lin, C.Y., Londe, H.F., Metchette, K., Nerio, A.T., Pu, J.T., Reames, A.A., Rheinschmidt, M., Tessman, J., Isaacs, S.T., Wollowitz, S. & Corash, L. (1997) Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion, 37, 423435.
  • Lin, L., Hanson, C.V., Alter, H.J., Jauvin, V., Bernard, K.A., Murthy, K.K., Metzel, P. & Corash, L. (2005) Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion, 45, 580590.
  • Lozano, M., Galan, A., Mazzara, R., Corash, L. & Escolar, G. (2007) Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions. Transfusion, 47, 666671.
  • McCullough, J., Vesole, D.H., Benjamin, R.J., Slichter, S.J., Pineda, A., Snyder, E., Stadtmauer, E.A., Lopez-Plaza, I., Coutre, S., Strauss, R.G., Goodnough, L.T., Fridey, J.L., Raife, T., Cable, R., Murphy, S., Howard, F., Davis, K., Lin, J.S., Metzel, P., Corash, L., Koutsoukos, A., Lin, L., Buchholz, D.H. & Conlan, M.G. (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood, 104, 15341541.
  • Miller, A.B., Hoogstraten, B., Staquet, M. & Winkler, A. (1981) Reporting results of cancer treatment. Cancer, 47, 207214.
  • Murphy, S. (2002) What’s so bad about old platelets? Transfusion, 42, 809811.
  • Murphy, S. & Gardner, F.H. (1975) Platelet storage at 22 degrees C: role of gas transport across plastic containers in maintenance of viability. Blood, 46, 209218.
  • Murphy, W.G., Foley, M., Doherty, C., Tierney, G., Kinsella, A., Salami, A., Cadden, E. & Coakley, P. (2008) Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sanguinis, 95, 1319.
  • Novak, M. (1939) Preservation of stored blood with sulfanilamide. Journal of American Medical Association, 113, 22272229.
  • Nussbaumer, W., Allersdorfer, D., Grabmer, C., Rheinschmidt, M., Lin, L., Schonitzer, D. & Lass-Florl, C. (2007) Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. Transfusion, 47, 11251133.
  • Osselaer, J.C., Doyen, C., Defoin, L., Debry, C., Goffaux, M., Messe, N., Van Hooydonk, M., Bosly, A., Lin, J.S., Lin, L. & Corash, L. (2009) Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use. Transfusion, 49, 14121422.
  • Pearce, S., Rowe, G.P. & Field, S.P. (2011) Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfusion Medicine, 21, 2532.
  • van Rhenen, D.J., Vermeij, J., Mayaudon, V., Hind, C., Lin, L. & Corash, L. (2000) Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sanguinis, 79, 206214.
  • van Rhenen, D., Gulliksson, H., Cazenave, J.P., Pamphilon, D., Ljungman, P., Kluter, H., Vermeij, H., Kappers-Klunne, M., de Greef, G., Laforet, M., Lioure, B., Davis, K., Marblie, S., Mayaudon, V., Flament, J., Conlan, M., Lin, L., Metzel, P., Buchholz, D. & Corash, L. (2003) Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood, 101, 24262433.
  • Simonsen, A.C., Johansson, P.I., Conlan, M.G., Jacquet, M., Lin, J.S., Junge, K., Lin, L., Sorensen, H., Borregaard, N. & Flament, J. (2006) Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study. Transfusion, 46, 424433.
  • Slichter, S.J., Raife, T.J., Davis, K., Rheinschmidt, M., Buchholz, D.H., Corash, L. & Conlan, M.G. (2006) Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia. Transfusion, 46, 731740.
  • Slichter, S.J., Kaufman, R.M., Assmann, S.F., McCullough, J., Triulzi, D.J., Strauss, R.G., Gernsheimer, T.B., Ness, P.M., Brecher, M.E., Josephson, C.D., Konkle, B.A., Woodson, R.D., Ortel, T.L., Hillyer, C.D., Skerrett, D.L., Mccrae, K.R., Sloan, S.R., Uhl, L., George, J.N., Aquino, V.M., Manno, C.S., Mcfarland, J.G., Hess, J.R., Leissinger, C. & Granger, S. (2010) Dose of prophylactic platelet transfusions and prevention of hemorrhage. New England Journal of Medicine, 362, 600613.
  • Snyder, E., Raife, T., Lin, L., Cimino, G., Metzel, P., Rheinschmidt, M., Baril, L., Davis, K., Buchholz, D.H., Corash, L. & Conlan, M.G. (2004) Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light. Transfusion, 44, 17321740.
  • Snyder, E., McCullough, J., Slichter, S.J., Strauss, R.G., Lopez-Plaza, I., Lin, J.S., Corash, L. & Conlan, M.G. (2005) Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion, 45, 18641875.